Medicare negotiations for lower drug prices near the finish line
![Medicare and drugmakers are in the midst of negotiations on price concessions for 10 popular and costly drugs ranging from blood thinners to diabetes treatments.](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/3616x2411+0+0/resize/3616x2411!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F58%2F77%2Fdc292ce44e699e490c9a040a1825%2Fdrug-prices-gettyimages-2163305420.jpg)
Medicare's new authority to negotiate lower prescription drug prices represents a signature accomplishment of the Biden-Harris administration. Here's what to know as the first set of talks wraps up.
(Image credit: Spencer Platt)
![](https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=g-s1-14346)